MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr | ₹-527 Cr | ₹-175 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-740 Cr |
Mar2022 | ₹605 Cr |
Mar2021 | ₹-7.81 Cr |
Mar2020 | ₹-527 Cr |
Mar2019 | ₹-175 Cr |
How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-740 Cr | Negative | |
Mar2022 | ₹605 Cr | Positive | |
Mar2021 | ₹-7.81 Cr | Negative | |
Mar2020 | ₹-527 Cr | Negative | |
Mar2019 | ₹-175 Cr | - |
Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹84,240.2 Cr | 0.1% | -11.8% | 59.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -1.1% | -2.9% | 55.1% | Stock Analytics | |
CIPLA | ₹118,275.0 Cr | 0.3% | 6.1% | 56.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹117,130.0 Cr | 8.2% | 11.5% | 27.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -3.7% | 8.5% | 107.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,034.1 Cr | 1.8% | -4.7% | 32.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.1% |
-11.8% |
59.3% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses